“…The embryonal carcinoma (EC) stem cell line, TERA2, readily differentiates into neuronal subtypes when exposed to ATRA. EC cells are the malignant counterpart of embryonic stem cells, and cells from the TERA2 lineage have provided the basis for many in vitro models of neural differentiation, function and neurite outgrowth (Tegengem et al., 2011, Satoh et al., 1997, Pewsey et al., 2010, Roloff et al., 2015, Przyborski, 2001, Przyborski et al., 2000, Przyborski et al., 2003, Przyborski et al., 2004, Stewart et al., 2004, Coyne et al., 2011). While such models are valuable, there is significant scope to enhance their reliability in terms of robustness and reproducibility.…”